Related Experiment Video
Updated: Jun 23, 2025

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Increased Expression of Orexin-A in Patients Affected by Polycystic Kidney Disease
Ersilia Nigro1,2, Daniela D'Arco2, Fiorenzo Moscatelli3
1Dipartimento di Scienze e Tecnologie Ambientali, Biologiche, Farmaceutiche, Università della Campania "Luigi Vanvitelli", Via Vivaldi 43, 81100 Caserta, Italy.
Abstract:
Orexin-A is a neuropeptide product of the lateral hypothalamus that acts on two receptors, OX1R and OX2R. The orexinergic system is involved in feeding, sleep, and pressure regulation. Recently, orexin-A levels have been found to be negatively correlated with renal function. Here, we analyzed orexin-A levels as well as the incidence of SNPs in the hypocretin neuropeptide precursor (HCRT) and its receptors, HCRTR1 and HCRTR2, in 64 patients affected by autosomal dominant polycystic kidney disease (ADPKD) bearing truncating mutations in the PKD1 or PKD2 genes. Twenty-four healthy volunteers constituted the control group. Serum orexin-A was assessed by ELISA, while the SNPs were investigated through Sanger sequencing. Correlations with the main clinical features of PKD patients were assessed. PKD patients showed impaired renal function (mean eGFR 67.8 ± 34.53) and a statistically higher systolic blood pressure compared with the control group (p < 0.001). Additionally, orexin-A levels in PKD patients were statistically higher than those in healthy controls (477.07 ± 69.42 pg/mL vs. 321.49 ± 78.01 pg/mL; p < 0.001). Furthermore, orexin-A inversely correlated with blood pressure (p = 0.0085), while a direct correlation with eGFR in PKD patients was found. None of the analyzed SNPs showed any association with orexin-A levels in PKD. In conclusion, our data highlights the emerging role of orexin-A in renal physiology and its potential relevance to PKD. Further research is essential to elucidate the intricate mechanisms underlying orexin-A signaling in renal function and its therapeutic implications for PKD and associated cardiovascular complications.
Insights
Elevated orexin-A levels are linked to impaired kidney function in autosomal dominant polycystic kidney disease (ADPKD) patients. This neuropeptide may play a role in renal and cardiovascular complications.
Area of Science:
- Neuropeptide signaling
- Renal physiology
- Cardiovascular health
Background:
- The orexinergic system, involving orexin-A, regulates feeding, sleep, and pressure.
- Recent findings suggest a negative correlation between orexin-A levels and renal function.
- Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder affecting kidney function.
Purpose of the Study:
- To investigate orexin-A levels and genetic variations in patients with ADPKD.
- To assess the correlation between orexin-A levels and clinical features of ADPKD.
- To explore the role of orexin-A in renal function and associated complications in ADPKD.
Main Methods:
- Serum orexin-A levels were measured using ELISA.
- Single nucleotide polymorphisms (SNPs) in HCRT, HCRTR1, and HCRTR2 were analyzed via Sanger sequencing.
- Correlations between orexin-A, SNPs, and clinical parameters (e.g., eGFR, blood pressure) were assessed in 64 ADPKD patients and 24 healthy controls.
Main Results:
- ADPKD patients exhibited impaired renal function (mean eGFR 67.8 ± 34.53) and higher systolic blood pressure compared to controls.
- Serum orexin-A levels were significantly higher in ADPKD patients (477.07 ± 69.42 pg/mL) than in healthy controls (321.49 ± 78.01 pg/mL).
- Orexin-A levels showed an inverse correlation with blood pressure and a direct correlation with estimated glomerular filtration rate (eGFR) in ADPKD patients. No significant SNPs were associated with orexin-A levels.
Conclusions:
- Orexin-A plays a significant role in renal physiology and may be relevant to ADPKD.
- Elevated orexin-A levels in ADPKD patients suggest its involvement in the disease's progression and associated cardiovascular issues.
- Further research is needed to understand orexin-A signaling mechanisms in renal function and its therapeutic potential for ADPKD.
More Related Videos
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
10:37Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Related Concept Videos
Nephrons
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Hormonal Regulation